You have 9 free searches left this month | for more free features.

Type I HAE

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hereditary Angioedema Trial (KVD900 600 mg)

Not yet recruiting
  • Hereditary Angioedema
  • KVD900 600 mg
  • (no location specified)
Aug 19, 2022

Lanadelumab in Teenagers and Hereditary Angioedema (HAE)

Not yet recruiting
  • Hereditary Angioedema (HAE)
  • No Intervention
  • London, England, United Kingdom
    Barts Health NHS Trust
Jul 20, 2022

Hereditary Angioedema Trial (KVD900 600 mg)

Not yet recruiting
  • Hereditary Angioedema
  • KVD900 600 mg
  • (no location specified)
Aug 17, 2022

Teenagers and Hereditary Angioedema Type I or Type II Who Use

Completed
  • Hereditary Angioedema (HAE)
    • Graz, Austria
    • +19 more
    Jan 12, 2023

    Biomarker for Hereditary AngioEdema Disease

    Completed
    • C1 Esterase Inhibitor Deficiency
    • +7 more
      • Yerevan, Armenia
      • +6 more
      Mar 23, 2022

      Lanadelumab in Persons With Hereditary Angioedema Type I or II

      Recruiting
      • Hereditary Angioedema (HAE)
        • Wien, Austria
        • +19 more
        Dec 13, 2021

        Angioedema, Hereditary, Types I and II Trial in Worldwide (KVD824, Placebo to KVD824)

        Recruiting
        • Angioedema, Hereditary, Types I and II
        • Birmingham, Alabama
        • +34 more
        Aug 9, 2022

        Lanadelumab in Persons With Hereditary Angioedema in Poland

        Recruiting
        • Hereditary Angioedema (HAE)
          • Wrocław, Dolnośląskie, Poland
          • +13 more
          Jun 15, 2022

          Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial (PHA-022121 low dose, PHA-022121 medium

          Recruiting
          • Hereditary Angioedema
          • +11 more
          • PHA-022121 low dose
          • +3 more
          • Birmingham, Alabama
          • +7 more
          Dec 5, 2022

          Lanadelumab in Persons With Hereditary Angioedema Type I or II

          Active, not recruiting
          • Hereditary Angioedema (HAE)
            • Birmingham, Alabama
            • +28 more
            Dec 17, 2021

            Hereditary Angioedema Trial in Canada, Puerto Rico, United States (Placebo, KVD900 600 mg, KVD900 300 mg)

            Recruiting
            • Hereditary Angioedema
            • Placebo
            • +2 more
            • Birmingham, Alabama
            • +14 more
            Jun 16, 2022

            Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial in Worldwide (PHA-022121, Placebo)

            Recruiting
            • Hereditary Angioedema
            • +9 more
            • Birmingham, Alabama
            • +21 more
            Aug 11, 2022

            Hereditary Angioedema (HAE) Trial in Worldwide (DX-2930 - 300mg/2wk, DX-2930 - 300mg/4wk, DX-2930 - 150mg/4wk)

            Completed
            • Hereditary Angioedema (HAE)
            • DX-2930 - 300mg/2wk
            • +3 more
            • Birmingham, Alabama
            • +40 more
            May 13, 2021

            Burden of Illness and Treatment Patterns in Teenagers and

            Recruiting
            • Hereditary Angioedema
              • Warszawa, Poland
              • +4 more
              May 6, 2022

              Hereditary Angioedema, HAE Trial in Worldwide (berotralstat)

              Active, not recruiting
              • Hereditary Angioedema
              • HAE
              • Brno, Czechia
              • +10 more
              Mar 2, 2022

              Complex Regional Pain Syndrome Type I Trial (Mirror Therapy exercise)

              Completed
              • Complex Regional Pain Syndrome Type I
              • Mirror Therapy exercise
              • (no location specified)
              Oct 20, 2023

              Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial in Worldwide (PHA-022121, Placebo)

              Active, not recruiting
              • Hereditary Angioedema
              • +9 more
              • Birmingham, Alabama
              • +35 more
              Aug 23, 2022

              Hypertension, Blood Pressure, Systolic Hypertension Trial in Seoul (CART-I Plus)

              Recruiting
              • Hypertension
              • +6 more
              • CART-I Plus
              • Seoul, Korea, Republic of
                Seoul National Univesity Hospital
              Oct 11, 2023

              Hereditary Angioedema Trial in Netherlands, United States (IONIS-PKK-LRx, Placebo)

              Completed
              • Hereditary Angioedema
              • Scottsdale, Arizona
              • +7 more
              Sep 15, 2022

              Type1diabetes Trial in Cairo (Detection of RAGE gene polymorphism (rs1800625))

              Completed
              • Type1diabetes
              • Detection of RAGE gene polymorphism (rs1800625)
              • Cairo, Egypt
                National Institute of Diabetes and Endocrinology's
              May 23, 2023

              Diabetes, Type 1 Trial in Abu Dhabi (Insulin injection and blood glucose)

              Completed
              • Diabetes Mellitus, Type 1
              • Insulin injection and blood glucose
              • Abu Dhabi, United Arab Emirates
                Hisham Ibrahim
              Sep 20, 2023

              Fatty Liver, Nonalcoholic Trial (SGLT2 inhibitor)

              Not yet recruiting
              • Fatty Liver, Nonalcoholic
              • SGLT2 inhibitor
              • (no location specified)
              Oct 31, 2023

              Mucopolysaccharidosis III-A Trial in Hamburg (JR-441)

              Recruiting
              • Mucopolysaccharidosis III-A
              • Hamburg, Germany
                Universitätsklinikum Hamburg-Eppendorf
              Oct 18, 2023

              Heart Failure Trial in New York (I-TRANSFER-HF)

              Not yet recruiting
              • Heart Failure
              • I-TRANSFER-HF
              • New York, New York
              • +1 more
              Oct 31, 2023

              Dental Implant Trial (Type I Dental implant placement., Type II Dental implant placement., Type III/IV dental implant

              Not yet recruiting
              • Dental Implant
              • Type I Dental implant placement.
              • +2 more
              • (no location specified)
              Aug 4, 2023